SCHEMBL9656109

SCHEMBL9656109

COc1ccc2ccccc2c1C(=O)C=Cc1ncn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
PKM P14618 1/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
BLM P54132 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ABCG2 Q9UNQ0 5/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CNR2 P34972 2/20 0.38
CNR1 P21554 1/20 0.38
CYP1A1 P04798 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9656100 1.00 KDM4E (0.49) KDM4EMEN1ALDH1A1LMNAPOLB
SCHEMBL9655717 0.88 ABCG2 (0.43) KDM4EMEN1ALDH1A1LMNAPOLB
SCHEMBL9655710 0.88 ABCG2 (0.43) KDM4EMEN1ALDH1A1LMNAPOLB
SCHEMBL9654491 0.84 TUBB4A (0.45) MEN1ALDH1A1LMNAMAPTHPGD
SCHEMBL9654480 0.84 TUBB4A (0.45) MEN1ALDH1A1LMNAMAPTHPGD
SCHEMBL9656211 0.82 CYP1B1 (0.44) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL9656194 0.82 CYP1B1 (0.44) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL9655756 0.78 RAB9A (0.46) KDM4EALDH1A1LMNAMAPTPKM
SCHEMBL9655749 0.78 RAB9A (0.46) KDM4EALDH1A1LMNAMAPTPKM
SCHEMBL9656710 0.78 CYP1B1 (0.50) KDM4EMEN1ALDH1A1MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5084474-A Antagonist of 5-hydroxytryptamine receptors on nerves and useful for treatment of psychotic disorders, anxiety, and nausea and vomiting, compounds of imidazole GLAXO GROUP LIMITED (GB) 1992-01-28 US disclosed
US-5019586-A 5-Hydroxytryptamine Receptor Antagonists GLAXO GROUP LIMITED 1991-05-28 US disclosed
US-4918080-A ANXIOLYTIC AGENTS, ANTIEMETICS GLAXO GROUP LIMITED (GB) 1990-04-17 US disclosed
EP-0291172-A1 Ketone derivatives GLAXO GROUP LIMITED (GB) 1988-11-17 EP disclosed